Biological Agents and Infectious Diseases

Contact Us

Lee Anne Nance

Chief Operating Officer
919-840-7372, ext. 3
LinkedIn Profile

Who you gonna call? PlagueBusters!

We’re the world’s top maker of vaccines, home to the nation’s No. 1 public university school of public health and a nexus for public, private and university partners who collaborate on solutions to some of the scariest threats on the planet.  

Whether it’s Ebola, HIV or a health crisis following a disaster, you’ll find people in the Research Triangle Region working on a cure or response.

They include the National Institute of Environmental Health Sciences, RTI International and U.S. Environmental Protection Agency, each contributing knowledge and solutions that improve health and well-being of people around the world.

They include companies that discover and develop infectious disease therapies of all kinds and specialized research centers that focus on combating agricultural disasters and bioterrorism, managing threats to the food supply, and providing safe, clean drinking water to communities around the world.

GSK, which developed AZT as a treatment for HIV here in the 1980s, now partners with UNC scientists to find a cure for HIV/AIDs.

Duke University’s Human Vaccine Institute is one of 13 National Institutes of Health-funded network of labs developing drugs and diagnostics for biodefense and emerging infections while standing by to respond in the event of a public health emergency.

Add other regional technology strengths – sensors, analytical instruments and data mining – and you’ve got a formula for breakthrough innovations in early detection of disease outbreaks, identifying new strains of pathogens or creating fabrics that keep infection from spreading.

Connect by being part of a Biological Agents and Infectious Diseases cluster that is making our world healthier and safer every day.